128 related articles for article (PubMed ID: 32319007)
1. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH
Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007
[TBL] [Abstract][Full Text] [Related]
2. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
3. [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy].
Yue X; Zhao PW; Liu ZS; Wu GF; Tu F; Hu JS; He XL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):560-4. PubMed ID: 26108313
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
[TBL] [Abstract][Full Text] [Related]
5. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.
Zhao Y; Diao Y; Wang X; Lin S; Wang M; Kang H; Yang P; Dai C; Liu X; Liu K; Li S; Zhu Y; Dai Z
Oncotarget; 2016 Sep; 7(36):58174-58180. PubMed ID: 27533457
[TBL] [Abstract][Full Text] [Related]
6. The Impact of TRAIL (C1595T and G1525A) and DR4 (rs20576) Gene Polymorphisms on Systemic Lupus Erythematosus.
Sandoughi M; Salimi S; Shahraki-Ghadimi H; Saravani M
Biochem Genet; 2020 Aug; 58(4):649-659. PubMed ID: 32342239
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk.
Qi GH; Wang CH; Zhang HG; Yu JG; Ding F; Song ZC; Xia QH
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597485
[TBL] [Abstract][Full Text] [Related]
8. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M
Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266
[TBL] [Abstract][Full Text] [Related]
9. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
Fathi F; Sadeghi E; Lotfi N; Hafezi H; Ahmadi M; Mozafarpoor S; Motedayyen H
Int J Immunogenet; 2020 Feb; 47(1):57-64. PubMed ID: 31565862
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
Hammad A; Mossad YM; Nasef N; Eid R
Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
12. Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus.
Wu CJ; Guo J; Luo HC; Wei CD; Wang CF; Lan Y; Wei YS
Rheumatol Int; 2016 Jan; 36(1):45-52. PubMed ID: 26289938
[TBL] [Abstract][Full Text] [Related]
13. The associations of hub gene polymorphisms in PI3K/AKT/mTOR pathway and Schistosomiasis Japonica infection and hepatic fibrosis.
Xiao Q; Yu H; Zhu X
Infect Genet Evol; 2020 Nov; 85():104423. PubMed ID: 32554084
[TBL] [Abstract][Full Text] [Related]
14. Association Between C1q, TRAIL, and Tim-1 Gene Polymorphisms and Systemic Lupus Erythematosus.
Yu Y; Zhu C; Zhou S; Chi S
Genet Test Mol Biomarkers; 2018 Sep; 22(9):546-553. PubMed ID: 30183357
[TBL] [Abstract][Full Text] [Related]
15. Association between IL-33 Gene Polymorphisms (rs1929992, rs7044343) and Systemic Lupus Erythematosus in a Chinese Han Population.
Xu W; Liu Y; Ye D
Immunol Invest; 2016 Oct; 45(7):575-83. PubMed ID: 27603301
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis.
Salimi S; Keshavarzi F; Mohammadpour-Gharehbagh A; Moodi M; Mousavi M; Karimian M; Sandoughi M
Gene; 2017 Dec; 637():161-172. PubMed ID: 28943344
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
Pasha HF; Tantawy EA; Youssef MA
Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
[TBL] [Abstract][Full Text] [Related]
18. The programmed cell death 1 gene 7209 C>T polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population.
Mostowska M; Wudarski M; Chwalińska-Sadowska H; Jagodziński PP
Clin Exp Rheumatol; 2008; 26(3):457-60. PubMed ID: 18578969
[TBL] [Abstract][Full Text] [Related]
19. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity.
Machado-Contreras JR; Muñoz-Valle JF; Cruz A; Salazar-Camarena DC; Marín-Rosales M; Palafox-Sánchez CA
Clin Exp Med; 2016 Aug; 16(3):399-406. PubMed ID: 26013387
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE.
Mohammadoo-Khorasani M; Salimi S; Tabatabai E; Sandoughi M; Zakeri Z; Farajian-Mashhadi F
Indian J Med Res; 2016 May; 143(5):591-6. PubMed ID: 27488002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
